Received Jun 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 3 | Y014059 | IM / LA |
Patient received first dose on 2/26, second dose on 3/31/25, and last dose on 6/25/25. According to ACIP guidelines, patient meets 2/3 requirements for the minimal intervals between doses. She meets the 4 week requirement between dose 1 and 2, and the 12 week requirement between dose 2 and 3. However, she does not meet the 5 month requirement between dose 1 and 3.
No Information available
No information available
No Prescriptions or OTCs filled at this pharmacy
No known allergies recorded
Patient plans to follow up with primary care provider to see how to proceed. No adverse effects reported from patient.